Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515995 · ClinicalTrials.gov registry record · Phase 4
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01515995 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT01515995, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as a vehicle for albuterol in children with moderate to severe asthma exacerbation.
Interventions
- DRUG Nebulized magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515995
The ClinicalTrials.gov registry entry for NCT01515995 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nebulized magnesium sulfate is the first listed.
NCT01515995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01515995 about?
NCT01515995 is a clinical study titled "Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation". The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as a vehicle for albuterol in children with moderate to severe asthma exacerbation.
What is the current status of trial NCT01515995?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01515995?
The interventions under investigation include: Nebulized magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT01515995?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.